MedPath

To compare sugammadex and neostigmine to acess hemodynamic response during the recovery of rocuronium in the brain surgery

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/07/070154
Lead Sponsor
DR KIRTI VERMA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All pateints age group 18-65years with craniotomy surgeries and giving written informed consent.

ASA GRADE 1 TO 3.

Exclusion Criteria

1.Pateint refuse to participate.

2.Renal,Hepatic,Ventilatory Dysfunction.

3.Increased intracranial pressure.

4.Pregnancy or lactation.

5.Pateints with muscular dystrophies,myopathy,or cerebral palsy.

6.Pateints with a history of intolerance to any of the study drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the hemodynamic response Heart rate,SBP,DBP,MAP,SPO2 of sugammadex versus Neostigmine in reversal of rocuronium in pateints undergoing craniotomy surgery.Timepoint: 2min,5min,10min,15min,30min,60min,2hr,6hr,12hr,18hr,24hr.
Secondary Outcome Measures
NameTimeMethod
1.To evaluate the side effects (PONV) of sugammadex versus neostigmine in reversal of rocuronium in pateints undergoing craniotomy surgery. <br/ ><br>2.To evaluate the Train of four Response of sugammadex versus neostigmine in reversal of rocuronium in pateints undergoing craniotomy surgery.Timepoint: 2min,5min,10min,15min,30min,60min,2hr,6hr,12hr,18hr,24hr. <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath